Hanaa M. Badran
Shebeen El Koom, Egypt
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
ALBI-sarcopenia score as a predictor of treatment outcomes in hepatocellular carcinoma.
Journal: Scientific reports
Published: December 26, 2024
Platelet-derived growth factor receptor-β as a non-invasive biomarker for liver fibrosis prediction in Egyptian diabetic patients with metabolic-associated fatty liver disease.
Journal: BMC gastroenterology
Published: August 08, 2024
Impacts of rifaximin and midodrine on morbidity, mortality, and quality of life in patients with decompensated liver cirrhosis.
Journal: European journal of gastroenterology & hepatology
Published: July 08, 2024
Appraisal of a newly developed ALBI-sarcopenia score as a prognostic marker in patients with hepatocellular carcinoma.
Journal: European journal of gastroenterology & hepatology
Published: April 16, 2024
Optimizing Prognostic Precision in Hepatocellular Carcinoma: Integrating PWR with ALBI and PALPI Scores.
Journal: Asian Pacific journal of cancer prevention : APJCP
Published: February 29, 2024
Impact of intermittent fasting on laboratory, radiological, and anthropometric parameters in NAFLD patients.
Journal: Clinical and experimental hepatology
Published: January 18, 2022
MELD-Sarcopenia is Better than ALBI and MELD Score in Patients with Hepatocellular Carcinoma Awaiting Liver Transplantation.
Journal: Asian Pacific journal of cancer prevention : APJCP
Published: July 02, 2020
Baseline Sarcopenia is Associated with Lack of Response to Therapy, Liver Decompensation and High Mortality in Hepatocellular Carcinoma Patients.
Journal: Asian Pacific journal of cancer prevention : APJCP
Published: June 21, 2020
Showing 1-9 of 9
Last Updated: 09/26/2026